These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8628501)
21. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Kaufman DW; Kelly JP; Anderson T; Harmon DC; Shapiro S Epilepsia; 1997 Dec; 38(12):1265-9. PubMed ID: 9578520 [TBL] [Abstract][Full Text] [Related]
23. Fatal liver failure following generalized tonic-clonic seizures. Brown SW; Clarke MA; Tomlin PI Seizure; 1992 Jun; 1(2):75-7. PubMed ID: 1344332 [TBL] [Abstract][Full Text] [Related]
24. Toxic epidermal necrolysis after initiation of felbamate therapy. Travaglini MT; Morrison RC; Ackerman BH; Haith LR; Patton ML Pharmacotherapy; 1995; 15(2):260-4. PubMed ID: 7624275 [TBL] [Abstract][Full Text] [Related]
25. Thrombocytopenia in association with adjunctive felbamate use. Ney GC; Schaul N; Loughlin J; Rai K; Chandra V Neurology; 1994 May; 44(5):980-1. PubMed ID: 8190314 [No Abstract] [Full Text] [Related]
26. Felbamate: a new antiepileptic drug. Brodie MJ Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147 [No Abstract] [Full Text] [Related]
27. Secondary mania associated with the use of felbamate. Hill RR; Stagno SJ; Tesar GE Psychosomatics; 1995; 36(4):404-6. PubMed ID: 7652143 [No Abstract] [Full Text] [Related]
28. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Felbamate Study Group in Lennox-Gastaut Syndrome N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179 [TBL] [Abstract][Full Text] [Related]
29. Felbamate: restrictions on use. Farrington E Pediatr Nurs; 1995; 21(2):188, 200. PubMed ID: 7746687 [No Abstract] [Full Text] [Related]
30. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622 [TBL] [Abstract][Full Text] [Related]
31. Is there any future for felbamate treatment? Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558 [TBL] [Abstract][Full Text] [Related]
35. Neuropsychiatric side effects related to treatment with felbamate. McConnell H; Snyder PJ; Duffy JD; Weilburg J; Valeriano J; Brillman J; Cress K; Cavalier J J Neuropsychiatry Clin Neurosci; 1996; 8(3):341-6. PubMed ID: 8854308 [TBL] [Abstract][Full Text] [Related]
36. Felbamate in an adult population with severe refractory epilepsy. Kearney H; Delanty N Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801 [TBL] [Abstract][Full Text] [Related]
37. Felbamate as an add-on therapy for refractory epilepsy. Shi LL; Dong J; Ni H; Geng J; Wu T Cochrane Database Syst Rev; 2011 Jan; (1):CD008295. PubMed ID: 21249704 [TBL] [Abstract][Full Text] [Related]
38. The use of felbamate to treat infantile spasms. Hurst DL; Rolan TD J Child Neurol; 1995 Mar; 10(2):134-6. PubMed ID: 7782604 [TBL] [Abstract][Full Text] [Related]
39. Warfarin-felbamate interaction: first report. Tisdel KA; Israel DS; Kolb KW Ann Pharmacother; 1994 Jun; 28(6):805. PubMed ID: 7919574 [No Abstract] [Full Text] [Related]
40. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview]. Steinhoff BJ Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]